A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TEs / thromboembolic events

[Related PubMed/MEDLINE]
Total Number of Papers: 59
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TEs  (>> Co-occurring Abbreviation)
Long Form:   thromboembolic events
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project. AHRE, CIED, HR, IR
2019 Bridging anticoagulation in patients treated with vitamin K antagonists prior to trochanteric and hip fracture surgeries: The current practice. OAC, SAEs, VKA
2019 Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin. AF, ICB, NOACs, RR
2019 Left Atrial Appendage Occlusion With Left Ventricular Assist Device Decreases Thromboembolic Events. LAAO, LVADs
2018 Accelerometer Detects Pump Thrombosis and Thromboembolic Events in an In vitro HVAD Circuit. LVAD
2018 Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis. AA, ADT, CIs, DVT, GnRH, HRs, PCa, PE
2018 Health Care Costs and Thromboembolic Events in Hydroxyurea-Treated Patients with Polycythemia Vera. HU, PV
2018 Incidence and Clinical Significance of New-Onset Device-Detected Atrial Tachyarrhythmia: A Meta-Analysis. DDAT, RR
2018 Meta-analysis of Clinical Outcomes of Electrical Cardioversion and Catheter Ablation in Patients with Atrial Fibrillation and Chronic Kidney Disease. AF, CA, CKD, ECV, eGFR
10  2018 The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). CVST, DVT, PNH, pts, PVT, VCT, WB-MRI
11  2018 Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study. ---
12  2018 Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study. AF, DOACs, IS/TIA, PY
13  2017 Antiplatelet drug resistance did not increase the thromboembolic events after stent-assisted coiling of unruptured intracranial aneurysm: a single center experience of 99 cases. SAC, UIA
14  2017 Practical Considerations for the Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation. AF, DOACs, VKAs
15  2016 A Novel Technique for Experimental Flow Visualization of Mechanical Valves. DBCS, SEM
16  2016 Adverse Events Following International Normalized Ratio Reversal in Intracerebral Hemorrhage. ICH, INR, IQR, PCCs, pmRS, VKAs
17  2015 Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis. ---
18  2015 Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation. AF, FU, OR, PY, SR
19  2014 Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation. AF, LAA
20  2014 Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 mug kg⁻) rFVIIa doses across clinical trials and registries. BPA, CHwI, rFVIIa
21  2014 Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter. AF, DCCV
22  2014 The effects of a low international normalized ratio on thromboembolic and bleeding complications in patients with mechanical mitral valve replacement. INR, MVR
23  2014 The risk of thromboembolic events in kidney transplant patients. KTRs, SIRs
24  2013 A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. AF, ATRIA, CVRN
25  2013 Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review. ACS, ACT, AF, APT, CCT, CENTRAL, INR, NIHR, RCTs, SE, WHO ICTRP
26  2013 Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. AF
27  2013 [Clinical features and risk factors of stroke/thromboembolism and bleeding in the elderly patients with atrial fibrillation]. AF
28  2012 Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer. BMI, CI, HR
29  2012 Androgen deprivation and thromboembolic events in men with prostate cancer. ADT
30  2012 Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study. IMN
31  2011 Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. aPL, CI
32  2011 Prevalence and predictors of warfarin use in patients with atrial fibrillation at low or intermediate risk and relation to thromboembolic events. AF, AFL, OR
33  2011 Use of low-molecular-weight heparin and a deep vein thrombosis protocol to prevent DVT in elderly patients with trauma. DVT, PEs
34  2010 A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing. ICER
35  2010 Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer. CALGB, FVL, ORs
36  2010 Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. rFVIIa
37  2009 Achieved anticoagulation vs prosthesis selection for mitral mechanical valve replacement: a population-based outcome study. HR, INRs, MVR
38  2009 Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. CI, ICU, ISS, LR, POC, rTEG
39  2009 Risk of thromboembolism following acute intracerebral hemorrhage. ICH, OAT
40  2009 Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. CVAD, HR
41  2009 Thrombophilic conditions in the adolescent: the gynecologic impact. ---
42  2008 Comparison of contemporary devices used for transcatheter patent foramen ovale closure. AF, PFO
43  2008 Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism. PFO
44  2008 Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism. PFO
45  2008 Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage. ICH, rFVIIa
46  2007 Thromboembolic events in children and young adults with pediatric sarcoma. ---
47  2006 Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial. cPPPM, INR, PSQ
48  2006 Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. AF, LARFA
49  2005 Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation. APCR, FV, FV, OLT
50  2005 Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study. AVR, INR, MVR, SJM
51  2004 Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. CC, INR, LMWH, VTE
52  2004 Low-molecular-weight heparin in pediatric patients. LMWH, UFH
53  2004 Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. LMWH, US
54  2003 Anticoagulation therapy in children. ---
55  2003 Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. SLE
56  2003 Thromboembolic diseases of childhood. ---
57  2003 Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. CHD, PT/INR
58  2000 The use of low molecular weight heparin in pediatric patients: a prospective cohort study. LMWHs
59  1999 Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. INR